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Cerebral Palsy 
Robert Skelton, '54 
Cerebral palsy is one of the ill-understood disease entities, 
which haJ· recei11ed very little medical attention in the past. It has 
only been in recent years tbat an awakening interest has developed 
in the eady treatment and rehabilitation of these patients. In this 
article Robert Skelton discusses the etiology, clinical types, diag-
nosis and treatment of cereb1·al palsy. 
CEREBRAL palsy by definition is a condition characterized by par-alysis, weakness, inco-ordination, or any other aberration of motor 
function due to pathology in the motor centres of the brain. It must be 
differentiated from (1) spinal palsy, e.g. poliomyelitis or that following 
transection of the cord; and (2) peripheral nerve palsy, eg. the paralysis 
of lead neuritis or severance of a nerve; (3) cerebral involvement which 
does not cause motor dysfunction, e.g . mentally deficient children who 
are retarded in motor development or children with central deafness or 
blindness. 
Incidence 
Most authorities agree that the incidence of cerebral palsv has been 
underestimated in the past. Dr. Winthrop Phelps, of Baltimore, believes 
cerebral palsy is a major cause of disability among children, ranking 
slightly behind poliomylelitis in incidence. 
On the basis of repeated samplings done in New Jersey and Mary-
land, ~s well as other areas, Dr. Phelps estimates that seven cases of 
cerebral palsy per 100,000 population are born every year. On the basis 
of these figures it has been computed that there exist 344,000 cases of 
cerebral palsy in the United States under the age of 40. Since cerebral 
palsy does not occur in epidemic form, similar to polio, the number of 
cases remains approximately the same from year to year. It is believed 
that better case reporting would very likely increase the known number 
of cases. 
Of the seven patients born each year per 100,000 population, one 
dies before reaching the age of six. Of the remaining six, two are feeble-
minded becaust> of their cerebral palsy and present a custodial rather 
than a rehabilitation problem. In the remaining four, one is so severely 
disabled that he must be classified as home-bound, a second suffers only 
the mildest handicap, and requires only a minimum of special handling 
before he merges into the general child population. These calculations 
leave two with handicap!'> of moderate severity who are ~entally normal. 
It is these two children who present the greatest problem in physical and 
academic education and rehabilitation. 
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Etiology 
There are certain factors which predispose to the occurrence of 
cerebral palsy. It is found to be more common among premature than 
among full term infants. Likewise, it is more common among first 
born children and those with heavy birth weights, where prolonged 
labour is more frequent . It occurs more frequently in children born to 
older women, who have on the average heavier babies; in boys, who on 
the average weigh more than girls at birth. It is higher among white 
children than coloured, due in part to the average smaller size of the 
coloured newborn infant and in part to the lower incidence of Rh 
negativity in this race. A racial factor may also possibly exist. There 
seems to be no economic, social or geographical predilections for cerebral 
p:1lsy. 
Pathogenesis 
Anoxia and cerebral hemorrhage are the two most important causes 
of cerebral palsy, and their pathogenetic relationship will be briefly 
reviewed. The brain is highly sensitive to an anoxic state, especially if 
prolonged, and it will cause irreparable damage to the nervous tissue 
which does not subsequently regenerate. Anoxia is highly selective in 
the damage that it causes. It affects primarily the basal nuclei and/ or 
their connections with resu ltant clinical findings of athetosis or involun-
tary movements. 
Actually anoxia plays a dual role causing primary structural dam-
age and a secondary effect on the cerebral vessels by increasing their per-
meability and fragility with the subsequent development of hemorrhage. 
Hemorrhages may also result from direct or indirect trauma to the 
brain or may be precipitated by bleeding tendencies, sudden pressure 
changes, or vascular spasm. Sites of predilection of brain hemorrhages 
in the newborn are in the vicinity of tears in the large veins and sinuses 
in the skull and under the meninges. Intracerebral episodes are less 
common, but occur in infants where maternal toxemia or hypertension 
exists. Occasionally, multiple minute hemorrhages may be seen in the 
cortex and subcortical areas . generally as a result of sudden pressure 
changes. Most cerebral hemorrhages are in the proximity of cortical 
motor areas or the internal capsule, thus the pyramidal tract area is more 
likely to be involved and as a result the clinical picture is usually that 
of a true spastic. 
Precipitating Factors 
These may be divided into factors occurring in the: 
( 1) prenatal period 
{2) natal period 
{3) postnatal period. 
Prenatal Causes 
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These may be divided into two classes: 
(a) Hereditary or genetic. 
(b) Congenitally acquired in utero. 
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(a) Hereditary (Genetic) CauseJ 
These causes include conditions which exist at birth or become mani-
fest soon after birth and which do not become progressively worse. 
These are referred to as static causes and many are familial. Spastic 
paraplegia in more than one member of a family may be the 
result of rudimentary pyramidal tracts. Likewise, atonic diplegias, con-
genital tremors, familial athetosis and rigidities due to developmental 
defects in the basal nuclei or tracts may be genetically transmitted. 
Congenital cerebellar defects may result in ataxia. Certain anomalies of 
metabolism may be associated with these cerebral defects and may be 
familial in nature, an example is phenyl pyruvic amentia. The various 
neurocutaneous syndromes due to ectodermal or mesodermal defects 
must be included in this group, such as tuberous sclerosis, Sturge-Weber 
syndrome, Von Hippel-Linhaus disease and others. 
Certain progressive hereditary anomalies must also be considered. 
These are not manifest at birth but appear later in life and are 
generally progressive. Actually their defects or anlage may be present 
at birth. Thus, the various forms of Tay-Sachs disease ( cerebro-
macular degeneration) or amaurotic familial idiocy may not become 
apparent until after the 6th to the 18th month of life or even later. The 
periaxial sclerosing degenerations are also progressive hereditary diseases. 
Wilson's disease (hepato-lenticular degeneration) and dystonia mus-
culorum deformans must also be considered as hereditary or genetically 
initiated. Genetic anomalies may also be precipitated by gonadal 
irradiations. 
(b) Congenitally Acquired Factors 
This refers to those factors not hereditary in character but which are 
due to noxae which affects the fetal brain as a result of disease or trauma 
to the mother or to the :1terus. These causes may be listed as: 
Anoxia 
(1) Anoxia 
(2) Cerebral Hemorrhage 
(3) Infection 
( 4) Metabolic Disturbances 
(5) Malnutrition 
(6) Rh Factor 
Any state that interferes with placental circulation is a potential 
cause of anoxia, e.g. compression of the umbilical cord between the head 
and bony pelvis; kinking of the cord ; threatened abortions or bleeding 
during pregnancy; premature separations and infarcts of the placenta; 
and decreased maternal blood pressure is also a potential cause of fetal 
anoxia. 
Cerebral Hemorrhage 
May be the result of fetal anoxia, direct trauma to fetus or uterus, 
maternal toxemia of pregnancy or blood dyscrasias. 
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·Infection 
Any maternal infection, especially with a neurotropic virus, may 
involve the fetal brain. Tn infants and children, the brain is more sus-
ceptible to viral infection due to a rich supply and higher metabolic rate. 
Certain viruses are more likely to cause fetal encephalitis than others. 
German measles is the most notorious. Involvement is not limited to the 
brain and a child may develop congenital heart disease, deafness, cataracts 
or auditory aphasia, as a result of the infectious process. Other viruses 
incriminated are, mumps, measles, chicken pox, herpes zoster and 
influenza. 
The spirochete of syphilis attacks nervous tissue and cerebral 
anomalies or active infection may result. These are manifested as a 
meningitis or gummata of brain at birth or a latent fo rm of parenchy-
matous neurosyphilis. 
Metabolic Disturbances 
Maternal diabetes with the development of hypoglycemia as a result 
of (1) insulin reactions, (2) spontaneous falls in blood sugar, (3) mater-
nal liver damage with disturbance in steroid and glycogen metabolism, 
will in turn result in a fetal hypoglycemia, which induces fetal anoxia. 
Other factors causing damage in children of diabetic mothers include 
excessive birth weight, and a predilection for these mothers to develop 
toxemias of pregnancy. 
Malnutrition and vitamin deficiencies may also be factors. Warkany 
has shown that in animals kept on a diet deficient in riboflavin congenital 
defects frequently occur in their offspring. 
Rh Factor 
This factor accounts for some 8]1o of all cases of cerebral palsy now 
seen. These cases result in a typical form of athetosis often associated 
with deafness and paralysis of extraocular muscles. 
Natal Causes 
These are classified in two main categories, anoxia, vascular damage 
and trauma. 
Anoxia may occur as the result of: (1) Mechanical obstruction of the 
respiratory tract. (2) Respiratory movements while in the birth canal 
with aspiration of mucus or amniotic fluid . (3) Depression of the respira-
tory centre by drugs such as morphine or some of the barbiturates. 
Obstetrical anesthesia may also asphyxiate the fetus. ( 4) Mechanics of 
birth: cerebral palsy is more commonly seen in breech deliveries. 
(5) Kinking or pinching of the cord. (6) Abruptio placenta, placenta 
previa and maternal anemia also are causes of anoxia. 
Vascular damage and traumas as causes of brain injury at birth are 
physiologic. The strong uterine contractions, and the resistant maternal 
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structures cause damage that cannot be avoided. This is especially true 
if there is a large baby andj or a small pelvis, and if the labour is pro-
longed and difficult. 
Trauma or mechanical injury to the skull and brain can cause 
hemorrhage as well as contusions. The classical example is, of course, 
the too strenuous application of forceps by the obstetrician; however, the 
obstetrician has been much maligned and such a mechanism accounts 
for less than 57< of all cases of cerebral palsy. 
Sudden pressure changes in precipitate deliveries or Caesarian sec-
tions can cause intracranial hemorrhages. Any condition which results in 
fragility of blood vessels may also cause cerebral hemorrhage. These 
are said to be seen in premature, debilitated or weak and syphilitic in-
fants which are both debilitated or weak and have their arteries spe-
cifically affected by their disease. Hemophilia may be the cause of intra-
cranial damage from bleeding, but more commonly there is a lack of 
vitamin K . This can be corrected by the administration of vitamin K 
to the mother prenatally. 
Post-natal Causes 
These include such causes as : (a) Trauma-direct effects from pene-
trating wounds and secondary effects due to hemorrhage; (b) Infections-
including meningitis, encephalitis, and brain abscesses following otitis 
media, anesthesia, lung abscess, etc.; (c) Neoplasms; (d) D1'ugs,-indud-
ing lead, arsenic and prolonged insulin reaction; (e) Vascular conditions-
in children the most common cause of a spontaneous cerebral hemorrhage 
is a rupture of a congenital aneurysm of the brain vessels. With senescene, 
however, arterial diseases develop with resultant arteriosclerosis and 
hypertension. Cerebral thrombosis due to arteriosclerosis, debilitation 
and syphilis is seen in older age groups. Vascular embolism where it 
occurs in children is generally due to endocarditis. In adults it may often 
follow septicemia, dislodgement of postoperative clots or diseases 
of the blood vessels. Sudden pressure changes as in Caisson's disease, 
exposure to low pressure in high altitude aircraft and blast injuries may 
cause minute hemorrhage in the- brain; (e) Anoxia-may arise from res-
piratory tract obstruction, from strangulation, drowning or carbon mon-
oxide poisoning. 
Oinical Differentiation 
The correct differentiation of clinical types is of considerable im-
portance so that the correct method of treatment might be instituted and 
the eventual prognosis esimated. 
(a) Spastic Type 
This type makes up 35-407< of all cases seen. Cerebral cortical dam-
age may produce spasticity, flaccidity or both, and most cases consist of 
an admixture of spasticity and flaccidity. Rarely is the damage limited 
to area 4, which produces almost complete flaccidity, instead of spasticitr 
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in the involved extremities. By examination an attempt should be made 
to determine which muscles are spastic, flaccid, normal, or normal but 
weak due to overstretching and disuse. 
The spastic type is a specific condition characterized by increased 
muscular tone. Stiffness is the outstanding clinical sign. Voluntary con-
trol of these spastic muscles is impaired, especially the finer and more 
discrete movements, which are rough and awkward. Extraocular muscles 
may be involved and cause strabismus. Swallowing and speech muscles 
may be involved as well and may constitute a serious handicap. 
There is a tendency for certain spastic muscles to be in more vigor-
ous contraction than other muscles and thus produce certain typical 
attitudes which are most noticeable on walking. In the lower extremi-
ties hyperactivity of the hip flexors, adductors and internal rotators, knee 
flexors and plantar flexors produces the so-called "scissors" gait. In 
the upper arm elbow flexors, forearm pronators, flexors of the wrist 
and fingers produce a typical attitude. The arm is usually adducted to 
the side but on walking may be held in abduction for balance. With 
prolonged contraction, the muscles shorten and persistent deformities 
result. 
Positive physical findings found in spastic types can be explained 
on the basis of an exaggerated deep tendon reflex. This phenomenon 
is produced by a mild stretching of the involved tendon which in the 
true spastic produces a hypercontractility of the muscle due to the loss 
of the inhibition affected by the normal cerebral cortex. These muscles 
are so affected that the attempted bending of a joint by an agonist throws 
the antagonist into a severe contraction, and in this manner, the motion 
is blocked. This is referred to as the stretch reflex. The deep reflexes 
in the spastic muscles are of course hyperactive and often clonus is 
present. 
(b) Athetoid Type 
This type is caused by damage to the basal ganglia which permits 
release of involuntary impulses from the cerebral cortex that are re· 
fleeted in many different types of involuntary motions. These motions 
may be rapid or slow, constant or intermittent, or may appear only on 
effort. Weird postural positions and attitudes which usually involve 
the entire body are produced but in some cases are one sided. It is sig-
nificant that these involuntary motions cease in sleep. Muscles inner-
vated by the cranial nerves may be involved similarly. AThere is consider-
able variation in the severity of different cases. In cases of damage to 
the base of the brain, constant grimacing may be produced by involve-
ment of the facial and speech muscles leading to the erroneous diagnosis 
of mental deficiency. 
Tension athetosis may be mistaken for spasticity which is developed 
to overcome involuntary actions. This differentiation is extremely im-
_portant surgically and these patients are referred to as " tension 
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athetoids" . The differentiation is made by the absence of a stretch 
reflex and the finding in the tension athetoid that the examiner is able 
to "shake loose" the tension by rapid passive flexion and extension of 
the involved joint. There is less tendency for fixed contractures in the 
tension athetoid than in the spastic type. 
(c) Ataxic Type 
A cerebellar lesion is the cause of the ataxia which is characterized 
by a loss of co-ordination. This is due to loss of synchronous muscle 
action in response to the change of position of the body. The ataxic 
patient retains his sense of balance on falling and will attempt to correct 
himself. Inco-ordination is demonstrated by the inability to perform 
skilled acts. It is probable that many mild cases go on unrecognized. 
In some cases the child may only be noticed to be clumsy and awkward 
in playing. No evidence is found in these patients of spasticity or athe-
tosis to account for their inco-ordination. 
The muscles of speech, of the trunk, as well as those of the ex-
tremities are involved. Thus these patients learn to walk late and are 
unable to walk on a narrow base. Their speech is poor due to ataxia of 
the tongue. Physical examination shows the typical reeling, unsteady 
gait, with wide base, past-pointing, nystagmus, vertigo, and other 
cerebellar neurologic signs. The typical ataxic cerebral palsy patient 
wil l improve spontaneously to a relatively greater degree than patients 
of the other types and is capable of learning voluntary balance control 
through re-education of the motor pathways. 
(d) Rigid Type 
This type is due to widespread brain damage and is usually asso-
ciated with severe mental deficiency. It is characterized by loss of 
elasticity of muscles, and a lead pipe response to passive movement of a 
joint. A sense of stiffness is encountered which is not due to a true 
stretch reflex. The patient is apt to lie in an opisthotonic position. Hyper-
tonicity increases when the child is disturbed and relaxation is noted to 
some degree on sleeping. The rigidities may be constant or intermittent 
and periods of rigidity and relaxation may be the predominant feature. 
The reflexes vary but usually are not hyperactive. These cases do not 
respond well to treatment. 
(e) Tremor Type 
This type is also due to a basal ganglia disturbance and is marked 
by vibratory, involuntary movements which are usually slow and rhyth-
mical. The tremors may sometimes be present during rest and are apt 
to become prominent on activity (intention tremor). Emotional excite-
ment also tends to accentuate the tremors. Many do not seek aid because 
the defect is only slight and not disabling. Exercises for relaxation and 
development of voluntary control are useful in overcoming these tremors. 
Diagnosis in Infancy 
The diagnosis of cerebral palsy may not be simple in the immediate 
period following birth. After a difficult delivery, the appearance of 
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convulsions, cyanosis, twitchings, etc., should arouse the physician's sus-
picions of a possible intracranial traumatic lesion. Other less reliable 
signs are irregular or difficult respirations, a poor cry and difficult nurs-
ing. The fontanelles should be examined for signs of increased intra-
cranial pressure. Bloody spinal fluid is suggestive but its absence does 
not rule out brain damage. 
The absence of clinical signs indicating location of the site of 
hemorrhage prevents surgical removal in most cases. In infants deep 
tendon reflexes and the Babinski sign are unreliable as are most other 
discrete neurologic tests. Pohl states that only 13% of cerebral palsy 
cases were recognized as abnormal by the parents during the first month 
of life. As the infant progresses in age the diagnosis becomes more 
evident. An easy and reliable method is to test the infant for the ability 
to hold up its head, which is usually present by 10 weeks of age. This 
may not be developed until much later in life in the cerebral palsy 
infant. It is helpful to trace a child's progress in development patterns 
of the use of upper and lower extremities, speech and intelligence. 
These normals can be found in any pediatric text book. 
Treatment 
Cerebral palsy by definition can of course occur at any age and 
must be treated medically or surgically as the case may be. The dis-
cussion of treatment will be confined to certain broad generalizations 
especially as they apply to the cerebral palsied child. 
Treatment must be divided into the specific treatment of the five 
separate groups, for the treatment of spastics, athetoids, ataxies, tremors 
and rigidity is all very different. 
Phelps believes that the basic fundamental of treatment of all types 
of cerebral palsy is the fact that the automatic functions such as recipro-
cal kicking for instance, are not learned. The sooner these automatic 
activities can be trained and established, the sooner a child will approach 
normal automatic activity. 
The task is difficult and results far from encouraging. The con-
tinuous change of methods used in treatment is proof alone that it is a 
difficult job. The approach is six fold: (1) physical therapy, (2) occu-
pational therapy, (3) speech therapy, (4) braces, (5) drugs, (6) surgery. 
One should keep in mind that spontaneous improvement will take 
place invariably and continue throughout adolescent years. This is due 
to the normal development of the central nervous system during this 
period and this must be considered in the evaluation of the effective-
ness of any therapy instituted. 
Drug Therapy 
Drugs play a very small part in the treatment of cerebral palsy. 
They are adjuvant therapy used to provide relaxation in order to do a 
test or J?le~t 3.:: social sit~ation . The drugs commonly employed are vita-
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mins, sedatives, Prostigmine, Curare, Myanesin, Tolserol, and Myoxerol. 
Atropine or Hyoscine are particularly useful in those cases in which 
there is tremor and cog-wheel rigidity. 
Surgery 
In cerebral palsy surgery is only a narrow aspect in a broad program 
of care. Earlier literature shows attempts to adopt procedures developed 
for polio to cerebral palsy. It has been appreciated that some degree of 
success was obtained in the spastic type but not in others. 
McCarrol organizes his prerequisites for surgery in the following 
four essentials: (1) a sense of balance adequate to permit the patient to 
stand and walk without support; (2) little or no athetosis; (3) enough 
intelligence to be able to understand and co-operate; ( 4) satisfactory 
speech. 
In the upper limb, the aim is to improve function and appearance. 
This is rarely attained by present day techniques. In the lower extremity 
one attempts to improve function and stability. 
The surgeon may direct his attention upon the following structures 
and attempt to modify them according to the individual's need: 
Muscles and tendons may be lengthened or divided to reduce their deform-
ing influence or may be transplanted to reinforce weaker muscles. 
Bones may be structurally revised to mechanically improve their function. 
N erves may be divided in part or in whole to reduce the activity or spas-
ticity of certain muscles or groups of muscles. 
Braces 
The two types of braces most commonly used are corrective braces 
and control braces. 
Control braces can be of great help to athetoids. Their construc-
tion must be much sturdier than that of a polio brace, since they must 
control the uninhibited movements of the athetoid. If the child wears 
a brace for two or three years a fairly well-appearing gait may develop. 
The brace may be removed and such a gait will continue for half an hoUJ; 
or so only to have the unwanted motions return . Further use of bracing 
will eventually lead to increasingly longer periods of time where they 
may go brace-free and eventually discard them altogether. 
Control braces are also designed for spastics to counteract their 
"scissors" gait. These braces must be very rigid through the hips. In the 
severe ataxias a similar control brace will aid in keeping a smooth walk-
ing pattern and prevent the patient from learning a distorted walk. 
The corrective brace is used to prevent deformities developing in 
the rather plastic limbs of a growing child due to the abnormal postures 
caused by the cerebral palsy. 
Braces are used as aids or adjuncts in the rehabilitation of these 
children, and should onlybe used when very definitely indicated. 
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Occupational, Physical and Speech Therapy 
This consists for the most part of careful training to establish nor-
mal automatic functions or re-education of faultily established patterns. 
These three spheres are considered by many as the most important aspects 
of treatment of the cerebral palsied child. Occupational therapy is to 
help the child learn simple skills that normal children are able to per-
form with little teaching, such as buttoning clothing, tying knots, etc. 
On the other hand, the physiotherapist teaches fundamental motions 
and functions. The aim is towards developing ability to obtain normal 
balance between flexors and extensors, accuracy of joint movement, 
relaxation during use of balance function. The development of speech 
is of course of immense importance, and it plays a vital role in the re-
habilitation program because it allows the child to express himself and 
consequently acquire a more pleasing personality. It stimulates mental 
growth and improves his chance of becoming a self-supporting member 
of society. 
Many other problems arise in the care of the cerebral palsied child. 
Assistance from psychologists, psychiatrists and social workers, will help 
to solve many of the educational recreational, emotional and vocational 
difficulties that tend to beset these unfortunate people. 
Summary 
Cerebral palsy is an aberration of motor function due to pathology 
in the motor control centres caused by conditions occurring in the pre-
natal , natal and postnatal stages of life. 
Five general clinical types are described: spastics, athetoids, ataxies, 
rigidities and tremor. Treatment varies according to the degree of in-
volvement and the specific clinical type and takes the form of: (1) ortho-
pedic surgery, (2) drug therapy, (3) psychological and social assistance, 
( 4) education by special methods, ( 5) opportunities for recreation, social 
contacts and objective relationships, ( 6) vocational guidance and train-
ing, (7) psychiatric guidance for child and parent. 
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Bronchiectasis* 
John C. Douglas, M.D. 
In recent years, certain changes in the nature of bronchiectasis 
and its management have begun to appear, and in this paper 
Dr. J. C. Douglas presents the revised picture of this common 
disease. 
BRONCHIECTASIS may be defined as a chronic pulmonary disease characterized by dilatation of the bronchi with destruction of the 
normal components of their walls, and usually with chronic infection of 
these bronchi and the surrounding lung parenchyma, plus fibrosis and 
collapse. 
Etiology 
Bronchiectasis is believed to follow a pneumonia which has in-
completely resolved, often an unrecognized bronchopneumonia compli-
cating one of the childhood infectious diseases. Foreign bodies or tumors 
of the bronchus with a pneumonia distal to them will cause bronchial 
ectasia. Some cases are undoubtedly congenital, and bronchiectasis may 
complicate pulmonary tuberculosis, although most of the latter cases 
involve upper lobes and drain well, thus causing few symptoms. Two 
factors are generally agreed to be necessary: a necrotizing infection of 
the bronchus and bronchial obstruction. 
Clinical Picture 
Most textbooks still describe the typical case as a sick person, 
dyspneic, often cyanosed, having profuse, foul sputum and clubbing of 
fingers , giving a history of hemoptysis, and faced with a very poor 
prognosis. 
The more usual case seen now in practice differs markedly from 
that described. He usually gives a history of the onset of symptoms 
following a pneumonia or one of the childhood infectious diseases 
(especially whooping cough or measles) , commonly during the first few 
years of life. Often there have been several pneumonias since onset. 
There will be a history of chronic cough, productive of varying 
amounts of sputum, usually purulent but seldom foul. There are fre-
quent respiratory infections, resulting in prolonged increases in sputum. 
Hemoptysis is relatively rare, as is dyspnea. (In the "dry" or "hemoptoic" 
type, hemoptysis may be the first and only symptom.) On examination, 
the subject is usually young - in childhood, teens or early twenties- and 
does not appear ill , but is more often well nourished and healthy in 
appearance. He is usually not dyspneic on exercise and seldom shows 
clubbing. Examination of the chest may show no abnormality; when 
• Paper read at the Thirteenth Dr. F. R. Eccles Memorial Medical Alumni Lecture, University 
of Western Ontario Medical School, London, Ontario, October 7, 1953. 
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findings are present, the commonest are a lag at one base, a few rhonchi 
andj or moist rales at one base, changing or disappearing with cough. 
Less commonly there will be dullness on percussion, shift of the heart 
and trachea, and bronchial breathing. Disease of the paranasal sinuses 
often coexists. 
Less commonly the subject will be older, showing emphysema and 
dyspnea. Or an adult may present a short history dating from a definite 
pneumonia occuring in adult life. 
Investigation 
Bacteriology is not much help in diagnosis, but may be invaluable in 
therapy. A variety of organisms may be cultured from the sputum, most 
of which represent secondary invaders. 
Plain ch"est films - Usually, although not always, the P.A. film will 
show some abnormality; collapse of a lobe, shift of organs {heart or 
diaphragm) , local emphysema, increased markings at one or both bases, 
ring shadows or closely grouped bronchovascular markings. 
Bronchoscopy- This procedure is not diagnostic, but is often useful 
for drainage prior to bronchography. 
Bronchography - For this examination, lipiodol is still used most 
commonly in this area. This substance (iodized peanut oil) is removed 
very slowly and may obscure the lung fields for months after use. Newer 
water soluble compounds are corning into use which are rapidly re-
moved and are less viscid; however, in some cases, these have given 
violent reactions with severe bronchospasm. No doubt more satisfactory 
compounds will be found. The techniques for bronchography comprise 
the catheter method (a urethral catheter passed through the larynx into 
one main bronchus) , the transglottic method where the oil is dripped 
through the anesthetized glottis by means of a curved canula, by means 
of a needle through the trachea, or through a bronchoscope (especially 
for small children). Anesthesia is usually topical (cocaine or pontocaine) 
except in the case of young children, where a general anesthetic is used. 
As a rule, one lung is mapped per session. Both lungs should be thor-
oughly mapped before surgery. 
Tests of Pulmonary Function -These are indicated in rare cases where 
surgical intervention is contemplated in the face of impaired pulmonary 
reserves. 
It is important to always bear in mind the possibility of bronchial 
tumor or foreign body. 
Treatment 
Medical Treatment 
The most important single feature is probably postural drainage. 
This measure is well known, but its _proper and efficient use is rare. 
Bronchoscopic drainage is sometimes indicated when secretions are 
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inspissated. Antibiotics, of course, play a major role and it is here that 
culture of organisms from the sputum and determination of their sensi-
tivity is important. Aerosol preparations of antibiotics are not now 
thought to be more effective than parenteral administrations and seem 
to lead to more frequent drug reactions. General health measures are 
important - proper food and rest, with avoidance of respiratory infec-
tion. Removal to a dry warm climate often accomplishes great improve-
ment in symptoms, but unfortunately is seldom practical for economic 
reasons. 
Surgical T reatment 
This therapy represents the only cure for bronchiectasis. Due to im-
provements in surgical and anesthetic techniques, the mortality from 
lobectomy has fallen to something under five per cent. 
An important question is which case is to be subjected to surgery. 
Factors which must be considered are: the age of the patient, the extent 
of the disease ( unilobular or multilobular), the severity of symptoms, 
and the success or failure of medical management. It must not be for-
gotten that the results following surgery are not satisfactory in many 
cases. Symptoms may persist due to coexisting chronic bronchitis or to 
residual bronchietatic areas. The long term result in terms of cardio-
pulmonary function may not be good. Although loss of actual lung 
tissue may not be very important, some sequels of intrathoracic surgery 
(pleural thickening and diaphragmatic adhesions) may result in severe 
loss of function and may even lead to eventual cor pulmonale. Over-
distention of the remaining lobe may lead to emphysema. These factors 
are, of course, much more important in bilateral surgery. 
Prognosis 
There has been little written on the prognosis of bronchiectasis 
since the advent of antibiotics. A recent article published in a leading 
medical journal quoted an 1871 publication to support the grave prog-
nosis of bronchiectasis untreated by surgery. Certainly the prognosis of 
this disease, whether medically or surgically treated, has vastly improved 
in recent years. 
Case Reports 
The following case reports illustrate the possibilities for manage-
ment of two typical bronchiectatic patients: 
Case I : A 23-year-old female giving a history dating from childhood of frequent 
chest colds in the fall and winter causing prolonged increase in her year-round 
purulent expectoration. There was no definite history of pneumonia at onset. 
She had an attack of pneumonia at 20 years of age. Her sputum had never been 
foul, nor had she ever spat blood. Investigation was instigated by a routine 
miniature chest film . 
On examination, she appeared well. There was no lag. An occasional musi-
cal rhonchus was heard over both lung bases. There was no emphysema or 
clubbing of fingers. She denied copious sputum, but when she was instructed 
in postural drainage and demonstrated, she produced four or five ounces of 
purulent greyish, non-foul sputum. She had no disease of the accessory nasal 
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sinuses. Her bro~chogram showed extensive cylindrical bronchiectasis of both 
lower lobes. 
For two years she has regularly practised postural drainage and has had 
several short courses of intramuscular penicillin for respiratory flare-ups. Her 
sputum has been reduced to a minimum, she has gained weight and has had 
fewer respiratory infections, and has lost only one day from work. 
The reasons for choosing medical management were the mildness 
of symptoms, the extensive nature of her disease (bilateral) and the 
excellent response to medical management. 
Case II: A 30-year-old housewife giving a history of a severe respiratory infec-
tion diagnosed as pneumonia at the age of one year, with chronic cough and 
sputum present since this attack. She had had severe respiratory infections every 
fall and winter, as well as three or four pneumonias since childhood. At least 
two of these pneumonias had been on the _left, since she remembered pleuritic 
pain. Her sputum was frequently foul. She had never spat blood. She had 
been laid up four to five weeks per year and complained of easy fatiguability. 
Sensitivity to penicillin had appeared one year previously. 
On examination, she was well nourished and did not appear seriously ill, 
although pale. Her fingers and toes showed definite clubbing. A lag on in-
spiration at the left base was present, and coarse moist rales were heard anter-
iorly and posteriorly at the left base which did not disappear with cough. No 
emphysema was evident clinically. No sinus disease was present. Bronchogram 
showed gross saccular bronchiectasis of the left lower lobe and lingula. 
She underwent a left lower lobectomy and lingulectomy without event. 
One year after operation, she was greatly improved, having only slight chronic 
cough with a small amount of sputum, usually mucoid. Her general health had 
improved, and she no longer suffered frequent severe respiratory infections. 
The reason for choosing surgical management was the presence of 
a definitely limited disease which was causing deterioration of health. 
Summary 
Bronchiectasis now shows lowered incidence and a more benign 
character, no doubt due to the advent of antibiotics and the more effec-
tive treatment of pneumonia. 
Much can be done in further lowering the incidence of this disease 
by the recognition and proper treatment of pneumonias, particularly 
those complicating the childhood infectious diseases. 
Many cases will do well on medical management. 
Surgical removal of the affected lung tissue provides the only cure, 
and should be considered if the disease is limited, if there is an unsatis-
factory response to medical management, and if symptoms are severe 
and are interfering with general health. 
Unsatisfactory results may follow surgery and are due to inadequate 
removal of the disease or persisting chronic bronchitis. 
Although multilobular surgery can be done now in many cases with 
apparent impunity, the state of the patient's cardio-pulmonary function 
in five or ten years must be borne in mind. This risk, of course, must be 
balanced against the threat to life provided by severe bronchiectasis. 
The decision regarding surgery can usually be postponed for a year 
during which time a thorough trial of medical management can be made, 
particularly since the disease is not progressive. 
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Erythromycin 
Lazarus J. Loeb, M.Sc. '54 
In this timely review of the literature of one of the newer and 
more promising antibiotics, L. f. Loeb discusses the pharmacology 
and the therapeutic importance of erythromycin. 
T HE advent of antibiotics as potent therapeutic weapons in bacterial infections has been one of the outstanding accomplishments of modern 
medical research. However, as the antibiotics become more widely used, 
their deficiencies and disadvantages become more evident. In order to 
overcome their deficiencies, and to fill the gaps not yet covered by the 
existing antibiotics, a systematic search is being conducted for new anti-
microbial substances. Erythromycin is a recently discovered antibiotic 
which has fulfilled the necessary laboratory and clinical requirements 
and is now being employed in the therapy of infections caused by Gram-
positive microorganisms, especially those due to penicillin-resistant strains. 
Source 
Erythromycin was first described by McGuire et al (1952) as the 
product of Streptomyces erythreus (Waksman) isolated from a soil sample 
from the island of Panay in the Phillipines. 
Physical and Otemical Properties 
The original product tested was a filtrate of Streptomyces erythreus 
grown in soybean meal-glucose medium in shake flasks. The purified 
substance is a whitish crystalline compound which is a base and readily 
forms salts with acids. It is slightly soluble in water to the extent of 
2 mg. per ml. It is readily soluble in alcohols, acetone and chloroform 
and is moderately soluble in ether, ethylene dichloride, and amyl acetate. 
Analysis of the dried preparation indicates a probable molecular formula 
of C 9 H1s 0 13 and a molecular weight of 766. There is no benzene ring 
structure present in the molecule. 
Haight and Finland (1952 a, 1952 b) confirmed and extended many 
of the original observations of McGuire et al (1952) on the properties of 
erythromycin. The crystalline product was stable at room temperature, 
while a sterile solution in broth retained its activity when stored for 
eight weeks at 4°C or frozen at -25°C. A solution kept at room tem-
perature (25°C) showed no loss of potency in 24 hours, slight loss after 
three days, with deterioration after one week. At 37°C, there was a 
decrease in antibacterial activity after 4- 7 days and the solution deter-
iorated progressively thereafter. Erythromycin is most active in a mod-
erately alkaline medium (around pH 8.0) similar to streptomycin. 
Certain chemical substances known to affect the activity of penicillin 
and streptomycin did not affect the activity of erythromycin. There was 
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no erythromycin- inhibiting substance produced by insensitive bacterial 
strains. However, erythromycin is destroyed by acidity (below pH 4.0) 
as found in the gastric contents of normal patients. 
Antimicrobial Activity 
Laboratory Studies in Vitro 
The antibacterial activity of erythromycin against Gram-positive bac-
teria is similar to that of penicillin. Strains of pathogenic straphylococci 
(Micrococcus pyogenes) appear to be moderately sensitive. Powell et al 
(1953) showed that a concentration of erythromycin above 1 microgram 
per mi. suppressed growth, while double this concentration was bacteri-
cidal. Most strains resistant to penicillin and other antibiotics were 
found to be sensitive to erythromycin, and it is with this group of organ-
isms that erythromycin is most useful therapeutically. 
Probably the most sensitive organisms encountered in laboratory tests 
were strains of Streptococcus pyogenes (Lancefield's group A) and Dip-
lococcus pneumonia. However, stains of viridans streptococci and enter-
ococci (Strep. fecalis) required higher concentrations for growth inhibition. 
Erythromycin was very active against strains of Corynebacterium 
diphtheriae. McGuire et al (1952) reported that erythromycin had con-
siderable activity against Mycobacterium tuberculosis (H37Rv) in vitro and 
in vivo in relatively low concentrations, but this was not corroborated in 
clinical trials. 
Among the Gram-negative organisms, erythromycin was found to be 
quite active against N eisseria gonorrhoea and Neisseria meningitidis. It 
was interesting that strains of H emo phi/us influenzae were inhibited at a 
concentration of 0.2 ug. per ml ., and it was active at a slightly higher 
concentration against Brucella strains. The enteric group of bacteria proved 
to be highly resistant to erythromycin. More than 50.0 ug. per ml. were 
required to inhibit strains of the coliforms, Salmonella and Shigella. As 
would be expected Proteus and Pseudomonas strains were also highly 
resistant. 
Laboratory Studies in Vivo 
These studies paralleled the in vitro results. McGuire et al (1952) 
indicated that the protective activity of this antibiotic was related to the 
blood levels obtained. Eryhromycin protected mice against 10 LD of 
Corynebacterium diptheriae and against injections of psittacosis virus. Powell 
et al (1953) were able to protect mice against Hemophilus pertussis. 
Erythromycin was effective against meningopneumonitis virus in mice. 
In its activity against lymphogranuloma venerum virus, erythromycin 
was not as effective as chlortetracycline (aureomycin). The rickettsia of 
epidemic typhus in ovo was suppressed. Erythromycin has no effect 
against the smaller viruses. 
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McGuire et aJ ( 1952) and McGowen et a/ ( 195 3) independently 
described the action of erythromycin against animal parasites. This anti-
biotic was effective in vivo, against Entamoeba histoylytica in rats, and was 
also active against Borrelia novyi, Trichomonas vaginaJis, and oxyurid in-
festation of mice. 
Comparison to Other Antibiotics 
As the antibacterial spectrum of erythromycin was elicited, studies 
were carried on to compare it with the effects of other antibiotics. 
Welch et a/ (1952) stated that "erythromycin has a bacterial spectrum 
similar to that of penicillin". They noted that erythromycin is more 
effective against streptococci and pneumonococci than chlortetracycline 
(aureomycin) , oxytetracycline (terramycin) and chloramphenicol. There 
is little difference among these in their effects on viruses and rickettsia. 
Haight and Finland (1952a) noted that erythromycin was less active 
than the "broad spectrum" antibiotics against the enteric group, but had 
similar activity against Hemophilus. Erythromycin probably is most closely 
related to carbomycin but inhibited test organisms in lower concentra-
tions. The most striking contrast of erythromycin in other antibiotics 
was that strains of staphylococci resistant to penicillin and the "broad 
spectrum" group were sensitive to erythromycin. 
Mode of Action 
At present the information regarding the mode of action of 
erythromycin is sparse. Heilman et a/ noted that erythromycin is bac-
tericidal for sensitive stains but its action is not rapid. Erythromycin 
may be either bacteriostatic or bactericidal, depending on the sensitivity 
of the organism and on the concentration of the antibiotic. It exerts its 
effect most readily against rapidly multiplying bacteria. 
Development of Resistance 
Resistance of Staphylococci against erythromycin could be induced 
in vitro according to McGuire et a/ but it was a gradual process, as that 
with penicillin. Haight and Finland (1952 d) stated that staphylococcal 
resistance could be induced to 100 mg. per ml. rapidly while resistance 
of streptoccocci was induced after many more transfers. 
Resistance in vivo occurred in strains of staphylococci, enterococci, and 
viridans streptococci after contact with the drug. There are few reports of 
naturally resistant variants of sensitive strains. Kirby, Forland and Maple 
(1953) noted that only 2% of penicillin resistant staphylococci are not 
affected by erythromycin. 
Cross resistance was not encountered between erythromycin and 
other antibiotics except carbomycin. Finland et aJ (1952) noted that 
repeated subculture of staphylococci and of certain strains of strepto-
cocci in the presence of increasing concentration of either erythromycin 
or carbomycin results in fairly rapid and marked increase in resistance 
to both antibiotics. 





When administered orally to patients and test subjects, erythromycin 
was absorbed but there was much variability in the blood levels obtained. 
Heilman et al (1953) reported that a dose of 0.75 gm. to 1.0 gm. given 
to patients resulted in adequate serum levels within three to four hours. 
Good levels were also obtained using 0.4- 0.5 gm. which gave less gastro-
intestinal irritation, but the serum concentration began to decline after 
four to six hours. Josselyn and Sylvester (1953) noted that erythromycin 
is readily absorbed in the upper gastro-intestinal tract, however, absorp-
tion was lessened or destruction was increased by gastric acidity and 
digestive enzymes in normal subjects. Higher blood levels were obtained 
in subjects with achlorhydria, for example, those having pernicious 
anemia. 
Kirby et al (1953) showed that coated tablets which resisted acid 
solution, disintegrated in from three to five minutes at pH 7 or higher 
and a dose of 0.5 gm. gave low blood concentrations for the first three 
to four hours, but many patients had adequate blood levels within two 
hours. The serum concentrations were over 1 ug. per ml., many between 
10- 20 ug. per ml. where patients received multiple doses. The blood 
levels were higher than those obtained on similar dosage levels with 
chlortetracycline or oxytetracycline and were comparable to the admin-
istration of 2 - 3 million units of penicillin. 
Special forms of erythromycin have been developed for oral admin-
istration to children where tablets cannot be given. Sylvester and Josse-
lyn (1953) reported on "Erythromycin stearate" prepared in an aqueous 
vehicle containing carboxyl methylcellulose as a suspending agent with 
sodium citrate as a buffer. This agent resisted destruction by gastric 
secretions and was readily absorbed. Blood levels were obtained which 
were in the range of in vitro sensitivity of susceptible organisms. The rela-
tionship of meals bad little or no effect on serum concentration. A more 
recent product is "Ilotycin (Erythromycin, Lilly) Ethyl Carbonate" which 
consists of dry granules to which water is added so that 5 ml. contains 
100 mg. of erythromycin. This suspension is not affected by gastric 
acidity and remains stable at room temperature for two weeks. 
Intravenous Administration 
Maple et al (1953) described the use of erythromycin given intra-
venously in a dose of 0.5 gm. in 200 ml. of saline solution, over a 30 
minute period, gave a high initial blood concentration of from 7 - 30 
ug. per ml. Thereafter, the concentration fell rapidly and at six hours 
ranged from 0.1- 1.0 ug. per ml. Adequate therapeutic concentrations 
were present when 1.0 gm. of erythromycin was administered as a con-
tinuous I.V. saline drip over a six hour period. Virtually no side re-
actions were encountered. Martin et al (1953) used an average dose of 
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250 mg. of erythromycin dissolved in buffered saline solution and ad-
ministered intravenously every six to eight hours. This method of ad-
ministration was found useful where a high initial concentration was 
required and for patients unable to take the antibiotic orally. 
Topical Application 
Livingood et al (1953) described the use of a 0.5«fo erythromycin oint-
ment for Gram-positive infections of the skin. Very few patients had 
sensitivity or irritant reactions, but the drug was not well tolerated by 
denuded or eczematized skin. A 1 «fo erythromycin ointment in a base of 
petrolatum and 5«fo heavy mineral oil was used by Robinson and 
Zeligman (1953) and no sensitivity reactions were encountered in 47 
patients. This antibiotic product proved successful in the treatment of 
pyogenic infections of the skin. However, Martin et al (1953) believe 
that ointments which contain erythromycin may cause an increase in the 
incidence of resistant strains of bacteria normally found on the skin, and 
did not advocate its use in this form. 
Concentrations in Body Fluids and Tissues 
The concentration of erythromycin in blood serum varies with the 
dosage given and other factors mentioned under absorption. For effec-
tive therapeutic dosage a blood concentration of from 5 to 10 ug. per ml. 
is optimum. The recommended dosages will be discussed subsequently. 
Erythromycin does not diffuse readily into the cerebrospinal fluid. 
When there was a therapeutically effective level in the blood serum less 
than half the patients examined had more than a trace in the C.S.F. 
Grigsby et al (1953) remarked that the irregular appearance of erythro-
mycin in the C.S.F. in meningitis would be inadequate to clear the 
infection. 
Heilman et al (1953) showed that erythromycin is present in the 
fetal circulation when therapeutically effective levels are present in the 
mothers serum. This is similar to penicillin and other antibiotics which 
traverse the placental barrier readily. 
Erythromycin apparently is present in a pleural effusion during 
adequate therapy and may be of value in the treatment of infections of 
the pleural cavity. Grigby et al (1953) showed that erythromycin also 
diffuses into ascitic fluid. Other studies have indicated that erythromycin 
diffuses rather readily and uniformly into most of the body tissues. 
Excretion 
Heilman et al (1952) studied the presence of erythromycin in the 
bile of patients having a tube in the common bile duct with normal liver 
function. They showed that erythromycin is concentrated in the liver 
and is excreted readily in the bile in a biologically active form. This 
contributes to the large amount of th~ drug found in the feces . 
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Haight and Finland (1952 a) reported that the amounts of erythro-
mycin found in the urine appear to be smalL and erratic after ingestion 
of a single or repeated small doses of the drug, especially early in the 
therapeutic course. After continuous therapy with divided doses, up to 
15% of the amount ingested daily could be demonstrated in active form 
in the urine. 
Large amounts of erythromycin have been recovered from feces. 
Oral administration and bile excretion contribute to the high concentra-
tion . The presence of erythromycin has a definite effect on the bacterial 
flora of the Gram-positive flora with the elimination of species of 
Clostridium from the feces. Martin et al (1953) noted that the elimination 
of Clostridia accounts for the odorless fecal specimens obtained from 
patients receiving erythromycin orally for several days. There is no 
appreciable effect on the coliforms or enterococci present. Erythromycin 
has been found to be effective in treating cases of staphylococcal enter-
ocolitis which may occur and be the cause of severe diarrhea which 
ensues after oral therapy with the "broad spectrum" antibiotics (Dearing 
and Heilman, 1953) . 
Toxicity 
The toxic effects of erythromycin therapy are remarkably low. 
Clinically, patients given 0.75- 1.0 gm. orally by Heilman et aJ (1953) 
often experienced gastro-intestinal irritation, including nausea, vomiting 
and occasionally diarrhea. Generally there was a lack of serious toxicity 
in the usual dosage range of from 0.3 to 0.5 gm. per dose. No tendency 
to develop avitaminosis during oral therapy was encountered, nor any 




The oral dosage originally outlined by Heilman and his colleagues 
has been only slightly modified in present day therapy. They recom-
mended 0.4 -0.5 gm. every six hours, reduced to 0.3 gm. if signs of 
toxicity become evident. Recently, Smith et aJ (1953) used 0.3- 0.5 gm. 
every six to eight hours, giving an overall daily dosage from one to 
two grams. 
Indications 
Erythromycin has been found to be very useful in the treatment of 
staphylococcal infections and gave good results in cases of septicemia, 
pyoderma, etc. Kirby and Ahern (1953) , echoing the remarks of others 
stated, "of the three antibiotics available for the treatment of resistant 
staphylococci- erythromycin, chloramphenicol and bacitracin - erythro-
mycin is the agent of choice because of the bactericidal action against 
staphylococci, and its low degree of toxicity" . It was noted that the re-
sponse to therapy is comparable to that observed with penicillin in infec-
tions caused by penicillin - sensitive strains. 
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Resistant strains of staphylococci, when present in the intestinal 
tract in large numbers, may produce varying degrees of gastro-intestinal 
and systemic manifestations. The stools of some patients who developed 
diarrhea after chlortetracycline and oxytetracycline therapy contained 
M. pyogenes in pure culture. Cases of subsequent fatal enterocolitis and 
septicemia have been reported. Dearing and Heilman (1953) showed 
that erythromycin (300- 400 mg. four times daily, orally) is capable of 
elimination of these resistant strains and the alleviation of untoward 
gastro-intestinal or systematic reactions. 
In the therapy of infections due to Streptococcus pyogenes (Group A), 
Heilman, and Haight and Finland reported good clinical response. Some 
strains of enterococci and viridans streptococci were not effectively dealt 
with, since erythromycin was not bactericidal in these cases and some 
organisms became resistant during the course of therapy. In an overall 
evaluation, Finland ( 1953) stated that in streptococcal infections 
erythromycin is less effective than penicillin. 
A generally good response of pneumococcal infections was reported 
by Haight and Finland (1952 a). The clinical effect was similar to that 
with sulphadiazine and other antibiotics; a definite improvement was 
noted in 24- 48 hours. However, in a report on twelve patients with 
pneumococcal pneumonia, Burn and Cook (1953) reported a good re-
sponse in five patients while seven patients showed slow resolution or 
failed to respond . It was concluded that "erythromycin is not the drug 
of choice for pneumococcal pneumonia". 
Heilman reported on a case of Hemophilus influenzae pharyngitis 
successfully treated with erythromycin. 
In the therapy with erythromycin Grigsby et al (1953) showed that 
three-fourths of the cases of acute gonococcal urethritis in females re-
sponded well, but Haight and Finland (1952 a) concluded that the 
results were not as good as with penicillin. Anderson (1953) reported 
on a case of meningococcemia where the organism was resistant to peni-
cillin and oxytetracycline. Erythromycin was found to be effective on 
the basis of sensitivity tests and proved successful clinically. 
There have been a few other reports of clinical trials with erythro-
mycin, but new therapeutic results will be reported soon on experiments 
now in progress. Generally, the consensus of opinion is that erythromycin 
will be useful in patients with penicillin sensitivity or in infections 
caused by penicillin resistant strains of bacteria. In the pneumonias 
erythromycin should be kept in reserve for penicillin - treated cases 
with poor results. 
Development of Resista11ce 
Cases of staphylococcal osteomyelitis reported by Heilman et al {1953) 
and Kirby et al (1953) did not respond well to erythromycin therapy. On 
subsequent laboratory testing it was found that the organism developed . 
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resistance to erythromycin in a high concentration. This pointed to the 
selection of a mutant rather than gradual increase in resistance during 
therapy. Finland ( 1953) noted that the failures encountered in patients 
with endocarditis were associated with the development of resistance 
in the strains of staphylococci and enterococci during treatment. In the 
routine testing for antibiotic sensitivity in the bacteriology laboratory 
at Victoria Hospital, London, the writer found that approximately 101o 
of staphylococcic strains were resistant to erythromycin. Most of these 
were resistant to other antibiotics: penicillin, streptomycin, chlortetra-
cycline and oxytetracycline, but not to chloramphenicol. 
Combined Therapy 
The use of antibiotics 10 combination has been of some value in 
enhancing their individual effects and decreasing their toxic side re-
actions. Finland (1953) noted that the combination of erythromycin 
with penicillin or streptomycin may increase their activity and delay or 
prevent the development of resistance. The use of erythromycin with 
streptomycin was recommended to widen the range activity to include 
Gram-positive and Gram-negative organisms when erythromycin is sub-
stituted for penicillin in penicillin-resistant infections. Powell et al 
{1953) found that synergism was apparent between erythromycin and 
sulphadiazine in experimental streptococcal infections in mice. This has 
been corroborated in clinical experiences with this combination. 
Summary and Conclusions 
1. Erythromycin is a recently discovered antibiotic produced by 
Steptomyces erythreus. It is a crystalline, basic substance slightly soluble 
in water, which is readily put into solution with a small amount of 
alcohol, to which water or saline are then added . This antibiotic is most 
active in a slightly alkaline medium. 
2. The "antibacterial spectrum" of erythromycin includes Gram-
positive organisms: staphylococci, streptococci, pneumococci, clostridia, 
and corynebacteria and a few Gram-negative bacteria: Neisseria, Hemo-
philus and Brucella strains. It has some activity against the psittacosis-
lymphogranuloma group of virus. Entamoeba histolytica and some other 
animal parasites appear to be sensitive to erythomycin. This range of 
organisms justified the designation of a "medium-spectrum" antibiotic. 
Erythromycin has a similar but quantitatively more effective action than 
carbomycin, these two antibiotics exhibit cross resistance. 
3. Erythromycin is usually given orally. It is partially destroyed 
by gastric acidity, but acid-resistant tablets are absorbed well in the upper 
intestine. The usual dose for adults is 200 - 400 mg. every six hours. 
Only minor gastro-intestinal upset has been reported in a few cases. The 
antibiotic diffuses readily through most body tissues with the exception 
of the cerebrospinal fluid especially where the meninges are inflamed. 
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It is concentrated and excreted in the bile, and large amounts are excreted 
in the urine. Erythromycin can be used intravenously without any sys-
temic toxic reaction. 
4. The main clinical use for erythromycin is in the treatment of 
infections attributable to strains of Micrococcus pyogenes (staphylococci) 
that are or may become resistant to penicillin or other commonly em-
ployed antibiotics. Only a small number of staphylococci are resistant 
to erythromycin, but in some instances of chronic infection the organ-
isms may become resistant rapidly. The combination of erythromycin 
with other antibiotics may prevent or delay development of resistance 
or may widen the range of effectiveness. Erythromycin is useful in cases 
of staphylococcal enterocolitis especially after therapy with broad spec-
trum antibiotics. The action of erythromycin against other bacteria has 
been discussed . This antibiotic may be useful in patients who are allergic 
to penicillin or in cases where the toxic effects of other antibiotics should 
be avoided . 
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Rheumatoid Arthritis: 
Douglas Boclcing, M.D. 
Although the etiology and pathogenesis of rheumatoid arth-
ritis remain obscure, significant advances in the management of 
this most crippling form of arthritis have been made in recent 
years. In this paper, Dr. D. Bocking discusses various methods 
of management of the patient which are of proven value, or are 
of value in selected cases as welt as methods, which are of doubt-
ful or no value. 
T HE importance of rheumatoid arthritis lies not only in its potential devastating effect on the joints and general well-being of the 
patient, but also in the serious consequences on the social and eco-
nomic life of the individual, family, community, business and industry. 
When one considers that cases of rheumatoid arthritis comprise approx-
imately one third of those attending rheumatic disease clinics, its im-
portance is further emphasized. 
Although many theories have been advanced to explain the etiology 
of rheumatoid arthritis, no comprehensive hypothesis which embraces 
all the known facts has yet been proposed. Among the more popular 
theories have been the infectious, metabolic, endocrine, neurogenic, 
psychogenic, and allergic. Despite its uncertain causation, a few facts 
have been established fairly definitely, which may shed some light on 
the disease mechanism. Among these known factors are: 
(1) a sex preponderance of 3:1 in women, 
(2) an average age of onset of approximately 40 years, although it may 
begin in infancy or after 70, 
(3) a definite familial tendency, 
( 4) an amelioration by pregnancy, or jaundice, and 
(5) peripheral vascular abnormalities in the form of excessive perspiration 
of the hands and feet, and Raynaud's phenomena of the fingers, which 
frequently precedes the onset of arthritis. 








emotional stress, or 
cold and damp weather. 
In addition to an awareness of the above-mentioned possible etio-
logical and precipitating factors, the attending physician should be pre-
pared to advise the patient on the posible future course of the disease. 
The patient and relatives commonly envision a gradual progression to 
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severe crippling, complete invalidism, and a bed or wheel-chair exist-
ence. Fortunately, only about 101j'0 of cases of rheumatoid arthritis fol-
low such a progressive downhill course. Another 15 to 201j'o have a 
solitary attack followed by complete remission. The remainder run a 
prolonged fluctuant course characterized by spontaneous exacerbations 
and remissions. It is important that both physician and patient be aware 
of the natural course of rheumatoid arthritis in order to avoid either 
undue optimism or excessive pessimism. As with any chronic disease, 
these patients require a great deal of encouragement and reassurance. 
An optimistic attitude is of inestimable value in their successful man-
agement. 
The actual methods employed in treatment can only be considered 
briefly in this paper. It is important to realize that each patient must 
be treated individually, depending on the severity, activity, and duration 
of the disease, and the site of joint involvement. Treatment can be 
considered under the following headings: 
I. Methods of Proven Value. 
II. Methods of Value in Selected Cases. 
III. Methods of Doubtful or No Value. 
I. Methods of Proven Value 
1. Rest: 
The importance of adequate rest cannot be over-stressed. During 
the acute phase, complete bed rest may be required, whereas later the 
amount of rest may be decreased gradually. 
2. Physiotherapy: 
Exercises and heat are extremely important and their main objec-
tives are to prevent joint deformities maintain joint motion, and to pre-
serve muscle strength. During the acute inflammatory phase, passive 
and active assisted exercises are commenced. As the arthritis improves, 
resistance exercises are instituted. A balanced program of exercise and 
rest for the involved joints is thus arrived at for each patient. The im-
portance of quadriceps exercises cannot be over-stressed when the knee 
joint is involved. 
3. Salicylates: 
These are still the best drug in the over-all management of rheuma-
toid arthritis. They should be prescribed in adequate amount-e.g. 4.0 
to 7.0 gm. daily. Experimental work now suggests that they exert an 
anti-inflammatory effect in addition to their analgesic action. Toxicity 
does not result from average therapeutic doses, and gastric irritation 
may be avoided by the use of buffered or enteric-coated pills. Codeine 
and other "pain-killers" should be prescribed seldomly because of the 
danger of addiction in chronic illness. 
4. General supportive therapy: 
The diet should be adjusted so as to restore these patients to their 
" ideal" weight, and supplementary vitamins may be prescribed. The 
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hypochromic anemia, which is observed frequently in rheumatoid arth-
ritis, often does not respond to oral iron medication. Intravenous iron 
therapy may be of value in certain cases, but should be used with cau-
tion. Blood transfusions also may be extremely beneficial. 
5. Psychotherapy: 
This is extremely important in treating these patients. Genuine 
and kindly interest, encouragement, and reassurance by the attending 
physician are of far more value in most cases than psychoanalytic inter-
views. Both patient and family require help in readjusting their lives 
to one of chronic illness. A trained social worker may be of real assist-
ance in this aspect of treatment. 
6. Orthopedic Measures: 
The insidious development of deformities, notably ulnar deviation 
of the fingers and flexion contractures of the knees, can be prevented 
to a large extent by the early use of plaster casts. These should be worn 
at night and during periods of rest in the day. The use of pillows under 
the knees contributes to knee deformities and should not be allowed. 
Complete immobilization of rheumatoid joints may be disastrous, with 
the rapid development of fibrous or bony ankylosis. Moving the joint 
through a full range of motion daily prevents the formation of fibrous 
adhesions. Other non-surgical measures include crutches, canes, braces, 
etc. 
Various surgical procedures have been developed. The most satis-
factory results have been obtained with arthroplasty of the elbow, or 
hip, acromioplasty, and metatarsal head resection. Usually these proce-
dures shoud be withheld until the disease is relatively inactive or 
apparently "burnt out". 
7. Rehabilitation: 
Measures employed in rehabilitating patients with rheumatoid arth-
ritis comprise one of the most important phases of treatment. Success 
depends upon the team-work of patient, nurse, physiotherapist, occupa-
tional therapist, social worker, orthopedic surgeon, and physician, the 
latter directing and co-ordinating the concerted efforts. It is best to 
set limited and obtainable objectives, and to re-assess the individual case 
frequently in order to evaluate progress and possible future goals. Un-
fortunately due to the natural course of the disease, valuable gains may 
be vitiated by an exacerbation of the arthritis. Nevertheless, these 
patients are extremely grateful for even relatively slight advances, e.g., 
ability to use crutches rather than being confined to wheel-chair or bed. 
Sheltered work shops or training courses for new occupations may be 
indicated also. 
II. Methods of Value in Selected Cases 
1. Chrysotherapy: 
This has not yet been accepted by all authors as being of proven 
value in the therapy of rheumatoid arthritis. Many workers feel that 
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the high incidence of toxic reactions does not warrant its use. Hench 
and others, however, feel that gold therapy is justified if the disease is 
still progressive despite an adequate trial of conservative management. 
Aqueous preparations of organic gold salts are preferable and the usual 
intra-muscular dose is 25 to 50 mg. weekly, after one or two smaller 
initial doses. After completing a course of 1000 mg., it appears prefer-
able to give a maintenance dose of 25 to 50 mg. every three or four 
weeks. Signs or symptoms of toxic effects should be watched for care-
fully- e.g., thrombocytopenia, agranulocytosis, aplastic anemia, derma-
titis, stomatitis, and nephritis. The patient should have frequent hemo-
globin, W.B.C., differential, and platelet estimations as well as urin-
alyses. If signs of a toxic reaction appear, the gold therapy should be 
stopped immediately. BAL and cortisone are now available for treat-
ment of the serious complications. Splenectomy is often of value in 
cases of thrombocytopenia due to chrysotherapy. 
2. Cortisone and ACTH 
Since the original discovery in 1948 by Hench and his co-workers 
of the dramatic and ameliorating effects of cortisone and ACTH on 
rheumatoid arthritis, the initial enthusiasm has been supplanted now by 
more careful selection of cases for this therapy. These agents suppress 
the active inflammatory process in the synovial membrane and other 
tissues, but exert no curative effect. The actual mechanism of the anti-
inflammatory action of cortisone is still unknown. It is obvious that 
cortisone will have no effect on the late stages of rheumatoid arthritis 
when there is fibrous or bony ankylosis of joints. 
Cortisone therapy should not be used for every case of rheumatoid 
arthritis, but reserved for the patient who is not improving, or shows 
progressive disease, despite adequate conservative therapy. At present 
the main contra-indications are active peptic ulcer, psychosis or severe 
psychoneurosis, active infection, e.g . tuberculosis, severe hypertension, 
diabetes mellitus, cardiac or renal failure. These conditions are not all 
absolute contra-indications and their relative importance must be bal-
anced against the severity of the arthritis. 
Whereas previously large initial doses of cortisone were recom-
mended, most clinics now favour starting treatment with smaller initial 
doses and gradually increasing to a satisfactory maintenance dosage. 
Experience now suggests that a "safe" maintenance dosage for long 
term treatment should not exceed 50 mg. daily for women or 75 mg. 
daily for men. Larger dosage schedules will result in most instances 
in the development of Cushingoid features and an increased incidence 
of serious side effects. Withdrawal of cortisone should be done gradu-
ally by 5 or 12.5 decrements. Hydrocortisone is now available for oral 
use. Compared with cortisone, a smaller dose of hydrocortisone is 
frequently effective and there is reputedly less sodium retention effect. 
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Patients receiving cortisone must be followed carefully with respect 
to disease activity, symptoms of possible complications, signs of hyper-
cortisonism, weight, blood pressure, urinalysis, and chest X-ray. If 
peripheral edema develops, it is usually controlled by salt restriction, 
supplementary potassium chloride, and mercurial diuretics. 
There is considerable evidence now to indicate that prolonged 
administration of cortisone results in temporary adrenocortical depres-
sion. At times of added stress, e.g. severe infection ,operations, or 
burns, relative adrenal insufficiency may develop and should be con-
trolled by much larger daily doses of cortisone, e.g. 100 - 200 mg. 
Prolonged maintenance therapy with ACTH which is given intra-
muscularly or intravenously, is usually not practical. It may be used, 
however, during exacerbations of the disease, or to stimulate the adrenal 
cortex while on prolonged cortisone therapy. 
3. Intra-articular Hydrocortiso11e: 
In selected cases, where infectious arthritis has been excluded, the 
intra-articular injection of Compound F may be beneficial. The usual 
indications are: 
(a) Active inflammation in one or two joinst accessable to injec-
tion. 
(b) In conjunction with systemic cortisone when one or two joints 
continue to be involved actively. 
(c) In conjunction with orthopedic procedures, e.g., joint manipu-
lation, wedging of casts, or arthroplasty. 
The results and duration of improvement are unpredictable. The usual 
dose ranges from 12.5 to 50 mg. ,depending on the size of the joint. 
4. Irradiation: 
Deep X-ray therapy is of little value in the peripheral form of 
rheumatoid arthritis but is often beneficial in cases of Marie-Strumpell 
Spondylitis. 
5. Phenylbutazone ("Butazolidine" ) 
This drug has undergone extensive clinical trials during the past 
four years. Its ultimate place in the management of rheumatoid arth-
ritis is still in doubt. In addition to an analgesic action, it also 
apparently exerts an anti-inflammatory effect. The average maintenance 
dose is from 300 to 600 mg. daily. Benefit, if it occurs, is usually apparent 
within a week to ten days. The risk of certain serious toxic effects 
must be weighed carefully against the possible therapeutic benefits. The 
most serious complication is agranulocytosis which has resulted in 
fatalities in a few reported instances. Other toxic effects include gastro-
intestinal irritation, edema; dermatitis, thrombocytopenia, and aplastic 
anemia. 
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ill. Methods of Doubtful or No Value 
The number of drugs and other therapy employed in the treatment 
of rheumatoid arthritis is legion. Space does not permit a discussion of 
these but a few may be listed, e.g. vaccines, antibiotics, foreign proteins, 
vitamin D , removal of foci of infection, post partum plasma, etc. 
Conclusion 
The management of rheumatoid arthritis has been outlined briefly, 
with particuar emphasis on the importance of a sound basic program 
of conservative measures. This may be supplemented in selected cases 
with cortisone or ACTH, intra-articular hydrocortisone, gold, or ir-
radiation (in cases with spinal involvement). Although no cure is 
available yet, the results of the above treatment are often extremely 
gratifying to the patient, the members of the family and the physician. 
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